1. Pink Sheet
  2. >>Vaccines

Is It Time To Think Beyond mRNA For COVID Vaccines? FDA Advisors Intrigued by Novavax As Booster

 
• By Sarah Karlin-Smith

Many VRBPAC committee members said they were impressed with Novavax’s booster data, including with its prototype vaccine, raising questions about whether non-mRNA vaccine platforms may be preferable to address COVID long-term.

novavax covid prototype vax
Some FDA vaccine advisors suggested looking beyond mRNA vaccines for COVID-19 boosters. • Source: Shutterstock

Some of the US Food and Drug Administration’s vaccine advisors expressed interest in using Novavax, Inc.’s currently unauthorized protein-based COVID-19 vaccine, NVX-CoV2373, as a booster candidate this fall to help elicit broader protection against new and future SARS-CoV-2 variants.

They pushed the agency to think more broadly about the booster topic than the FDA seemed willing during the 28...

More from Vaccines

More from Pink Sheet